Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | DCAL Dishman Carbogen Amcis Limited Pharma · Small | COHANCE Cohance Lifesciences Limited Pharma · Small | SYNGENE Syngene International Limited Pharma · Small | AARTIPHARM Aarti Pharmalabs Limited Pharma · Micro |
|---|---|---|---|---|
| Final Score | 55 | 30 | 29 | 35 |
| Verdict | FAIR VALUE | OVERVALUED | OVERVALUED | WATCHLIST |
| Style | Growth at Value | OVERVALUED | OVERVALUED | WATCHLIST |
| Piotroski | 8/9 | 7/9 | 8/9 | 8/9 |
| Valuation | 16/30 | 1/30 | 2/30 | 7/30 |
| Growth | 20/25 | 7/25 | 7/25 | 12/25 |
| Quality | 0/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 4/15 | 10/15 | 11/15 | 8/15 |
| Cash Flow | 10/10 | 6/10 | 4/10 | 2/10 |
| Price | ₹189 | ₹432.4 | ₹444.3 | ₹625.25 |
| P/E | 29.10 | 82.30 | 48.30 | 31.10 |
| P/B | 0.43 | 4.16 | 3.75 | 2.59 |
| ROE | 1.58% | 7.04% | 7.86% | 8.59% |
| ROCE | 3.15% | 8.35% | 10.10% | 10.70% |
| Debt / Equity | 0.46 | 0.10 | 0.09 | 0.43 |
| FCF Yield | 8.52% | 0.70% | 0.30% | — |
| Dividend Y | — | — | 0.28% | 0.82% |
| Altman Z | 1.71 | 7.19 | 7.00 | 3.65 |
| Promoter % | 59.32% | 57.49% | 52.68% | 43.08% |
| Mkt Cap (₹Cr) | 2887.00 | 16238.00 | 18147.00 | 5497.00 |
| Graham # | ₹244.17 | ₹103.64 | ₹145.68 | ₹318.52 |
| Fair PE | 42.0 | 3.8 | 8.3 | 42.0 |
| MoS % | +27.6% | -2350.7% | -581.9% | +22.7% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startDCAL99
COHANCE40
SYNGENE49
AARTIPHARM95